We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Association Between Levels of D-Dimer, Fibrinogen and PAI-1 in Elderly Patients With Infection and Occurrence of Cardio- and Cerebro-vascular Disease After Discharge

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00512603
Recruitment Status : Completed
First Posted : August 7, 2007
Last Update Posted : January 16, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The association between the levels of d-dimer, fibrinogen and PAI-1 in plasma of elderly patients admitted to internal medicine departments because of infection and the occurrence of cardio- and cerebro-vascular disease after discharge

Condition or disease
Infection Acute Coronary Syndrome Cerebrovascular Disease

Study Design

Study Type : Observational
Actual Enrollment : 52 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 2007
Primary Completion Date : January 2008
Study Completion Date : July 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. thrombosis [ Time Frame: 24 months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Elderly patients hospitalized due to infections
Criteria

Inclusion Criteria:

  • Acute infection

Exclusion Criteria:

  • Anticoagulant therapy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00512603


Sponsors and Collaborators
Wolfson Medical Center
Investigators
Principal Investigator: Asher Winder, MD Wolfson Medical Center
More Information

Responsible Party: Asher Winder, Senior Physician, Institute of Hematology, Wolfson Medical Center, Holon, Israel. Responsible of Thrombosis & Hemostasis clinic, Wolfson Medical Center
ClinicalTrials.gov Identifier: NCT00512603     History of Changes
Other Study ID Numbers: DD-CVD-1
First Posted: August 7, 2007    Key Record Dates
Last Update Posted: January 16, 2013
Last Verified: May 2007

Keywords provided by Asher Winder, Wolfson Medical Center:
cerebro vascular event

Additional relevant MeSH terms:
Infection
Acute Coronary Syndrome
Cerebrovascular Disorders
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases